Dolastatin 10 (326) exhibits cytotoxic effects against human lung and breast cancer cell lines via both Bcl-2 phosphorylation and caspase-3 protein activation, and it modulates p53 oncoproteins in human diffuse large-cell lymphoma [735,736]. This evidence concerns the gene TP53 and breast cancer.